We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GlucoTrack Inc, former Integrity Applications, Inc. is a medical device company. The Company is focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by persons suffering from diabetes. It has developed a non-invasive blood glucose monitor, the G... GlucoTrack Inc, former Integrity Applications, Inc. is a medical device company. The Company is focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by persons suffering from diabetes. It has developed a non-invasive blood glucose monitor, the GlucoTrack Model DF-F glucose monitoring device, which is designed to help people with diabetes obtain blood glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot finger stick devices. The Company operates in Europe, and Asia and Pacific. The GlucoTrack model DF-F utilizes a combination of ultrasound, electromagnetic and thermal technologies to obtain blood glucose measurements in less than one minute through a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood. Show more
Continuous blood glucose monitor’s preclinical data and sensor longevity modeling to be presented at major diabetes conference Rutherford, NJ, May 02, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc...
Rutherford, NJ, April 22, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and...
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING Expansion offers the potential for continuous, discreet and simplified...
Expansion offers the potential for continuous, discreet and simplified epidural glucose monitoring solutions for patients with Painful Diabetic Neuropathy Rutherford, NJ, April 16, 2024 (GLOBE...
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR Computational modeling with The Technology Partnership...
Computational modeling with The Technology Partnership shows sensor longevity beyond 3 years; 1 year longer than previously announced Implantable Continuous Blood Glucose Monitor technology could...
Rutherford, NJ, March 12, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and...
Glucotrack selects cirtec medical as manufacturer for its implantable continuous blood glucose monitorRutherford, NJ & Brooklyn Park, MN, Feb. 27, 2024 -- InvestorsHub NewsWire -- Glucotrack, Inc...
Rutherford, NJ & Brooklyn Park, MN, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1112 | 23.2198788891 | 0.4789 | 0.61 | 0.4521 | 175981 | 0.53175146 | CS |
4 | 0.1902 | 47.5618904726 | 0.3999 | 0.99 | 0.36 | 347890 | 0.55823633 | CS |
12 | 0.3701 | 168.227272727 | 0.22 | 0.99 | 0.1981 | 198184 | 0.45531044 | CS |
26 | 0.4019 | 213.549415515 | 0.1882 | 0.99 | 0.1328 | 261782 | 0.29667523 | CS |
52 | 0.2082 | 54.516889238 | 0.3819 | 0.99 | 0.1328 | 225892 | 0.34197423 | CS |
156 | -2.5699 | -81.3259493671 | 3.16 | 4.24 | 0.1328 | 423977 | 1.81183757 | CS |
260 | -2.5699 | -81.3259493671 | 3.16 | 4.24 | 0.1328 | 423977 | 1.81183757 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions